BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 20138413)

  • 1. Early urinary markers of diabetic kidney disease: a nested case-control study from the Diabetes Control and Complications Trial (DCCT).
    Kern EF; Erhard P; Sun W; Genuth S; Weiss MF
    Am J Kidney Dis; 2010 May; 55(5):824-34. PubMed ID: 20138413
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dissociation between urinary pyrraline and pentosidine concentrations in diabetic patients with advanced nephropathy.
    Aso Y; Takanashi K; Sekine K; Yoshida N; Takebayashi K; Yoshihara K; Inukai T
    J Lab Clin Med; 2004 Aug; 144(2):92-9. PubMed ID: 15322503
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Albuminuria Changes and Cardiovascular and Renal Outcomes in Type 1 Diabetes: The DCCT/EDIC Study.
    de Boer IH; Gao X; Cleary PA; Bebu I; Lachin JM; Molitch ME; Orchard T; Paterson AD; Perkins BA; Steffes MW; Zinman B;
    Clin J Am Soc Nephrol; 2016 Nov; 11(11):1969-1977. PubMed ID: 27797889
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advanced glycation urinary protein-bound biomarkers and severity of diabetic nephropathy in man.
    Coughlan MT; Patel SK; Jerums G; Penfold SA; Nguyen TV; Sourris KC; Panagiotopoulos S; Srivastava PM; Cooper ME; Burrell LM; Macisaac RJ; Forbes JM
    Am J Nephrol; 2011; 34(4):347-55. PubMed ID: 21876347
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and progression of renal insufficiency with and without albuminuria in adults with type 1 diabetes in the diabetes control and complications trial and the epidemiology of diabetes interventions and complications study.
    Molitch ME; Steffes M; Sun W; Rutledge B; Cleary P; de Boer IH; Zinman B; Lachin J;
    Diabetes Care; 2010 Jul; 33(7):1536-43. PubMed ID: 20413518
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urinary albumin excretion rate and glomerular filtration rate in the prediction of diabetic nephropathy; a long-term follow-up study of childhood onset type-1 diabetic patients.
    Dahlquist G; Stattin EL; Rudberg S
    Nephrol Dial Transplant; 2001 Jul; 16(7):1382-6. PubMed ID: 11427629
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum amyloid A and C-reactive protein levels may predict microalbuminuria and macroalbuminuria in newly diagnosed type 1 diabetic patients.
    Overgaard AJ; McGuire JN; Hovind P; Parving HH; Rossing P; Pociot F
    J Diabetes Complications; 2013; 27(1):59-63. PubMed ID: 22885250
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regression of microalbuminuria in type 1 diabetes is associated with lower levels of urinary tubular injury biomarkers, kidney injury molecule-1, and N-acetyl-β-D-glucosaminidase.
    Vaidya VS; Niewczas MA; Ficociello LH; Johnson AC; Collings FB; Warram JH; Krolewski AS; Bonventre JV
    Kidney Int; 2011 Feb; 79(4):464-70. PubMed ID: 20980978
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term intra-individual variability of albuminuria in type 2 diabetes mellitus: implications for categorization of albumin excretion rate.
    Leong A; Ekinci EI; Nguyen C; Milne M; Hachem M; Dobson M; MacIsaac RJ; Jerums G
    BMC Nephrol; 2017 Dec; 18(1):355. PubMed ID: 29207965
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urinary N-acetyl B glucosaminidase as an earlier marker of diabetic nephropathy and influence of low-dose perindopril/indapamide combination.
    Basturk T; Altuntaş Y; Kurklu A; Aydin L; Eren N; Unsal A
    Ren Fail; 2006; 28(2):125-8. PubMed ID: 16538969
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microalbuminuria among Type 1 and Type 2 diabetic patients of African origin in Dar Es Salaam, Tanzania.
    Lutale JJ; Thordarson H; Abbas ZG; Vetvik K
    BMC Nephrol; 2007 Jan; 8():2. PubMed ID: 17224056
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urinary N-acetyl-beta-D-glucosaminidase in children with diabetes as an early marker of diabetic nephropathy.
    Abdel Shakour S; el-Hefnawy H; el-Yamani MY; Azmi Y
    East Mediterr Health J; 2002 Jan; 8(1):24-30. PubMed ID: 15330557
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kidney disease and related findings in the diabetes control and complications trial/epidemiology of diabetes interventions and complications study.
    de Boer IH;
    Diabetes Care; 2014; 37(1):24-30. PubMed ID: 24356594
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decreased plasma levels of select very long chain ceramide species are associated with the development of nephropathy in type 1 diabetes.
    Klein RL; Hammad SM; Baker NL; Hunt KJ; Al Gadban MM; Cleary PA; Virella G; Lopes-Virella MF;
    Metabolism; 2014 Oct; 63(10):1287-95. PubMed ID: 25088746
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urinary activities of cathepsin B, N-acetyl-beta-D-glucosaminidase, and albuminuria in patients with type 2 diabetes mellitus.
    Piwowar A; Knapik-Kordecka M; Fus I; Warwas M
    Med Sci Monit; 2006 May; 12(5):CR210-4. PubMed ID: 16641878
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urinary excretion of beta-thromboglobulin and N-acetyl-beta-D-glucosaminidase in type 1 diabetes: potential indicators of early nephropathy?
    Patrick AW; Oliver MD; Howie AF; Dawes J; Macintyre CC; Frier BM
    Diabete Metab; 1990; 16(5):441-7. PubMed ID: 2150050
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clustering of long-term complications in families with diabetes in the diabetes control and complications trial. The Diabetes Control and Complications Trial Research Group.
    Diabetes; 1997 Nov; 46(11):1829-39. PubMed ID: 9356033
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urinary N-acetyl-beta-D-glucosaminidase activity in type I diabetes mellitus.
    Mungan N; Yuksel B; Bakman M; Topaloglu AK; Ozer G
    Indian Pediatr; 2003 May; 40(5):410-4. PubMed ID: 12768043
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of urinary albumin-creatinine ratio and albumin excretion rate in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications study.
    Younes N; Cleary PA; Steffes MW; de Boer IH; Molitch ME; Rutledge BN; Lachin JM; Dahms W;
    Clin J Am Soc Nephrol; 2010 Jul; 5(7):1235-42. PubMed ID: 20448066
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urinary excretion of type IV collagen and laminin in the evaluation of nephropathy in NIDDM: comparison with urinary albumin and markers of tubular dysfunction and/or damage.
    Banu N; Hara H; Okamura M; Egusa G; Yamakido M
    Diabetes Res Clin Pract; 1995 Jul; 29(1):57-67. PubMed ID: 8593760
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.